Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Tirofiban

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 3 USDMF, 2 EU WC, 2 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

29 FDF Dossiers, 10 FDA Orange Book, 7 Europe, 1 Canada, 2 Australia, 3 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INJECTION - EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Kirsch Pharma, 4 Actylis

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 2 Controlled & Modified Release

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 15 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices

1 Regulatory FDF Prices

MARKET PLACE

3 FDF Dossiers

3 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

15 Others

15 Others

$ Xls

Filters

SOLUTION;INJECTION - EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Tirofiban

Tirofiban

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers

3 USDMF

2 EU WC

2 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

29 FDF Dossiers

10 FDA Orange Book

7 Europe

1 Canada

2 Australia

3 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INJECTION - EQ 3.75MG BASE/15ML (EQ 0.25MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Kirsch Pharma

4 Actylis

EXCIPIENTS BY APPLICATIONS

3 Parenteral

2 Controlled & Modified Release

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

15 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices

MARKET PLACE

3 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

15 Others

Filters